DOI QR코드

DOI QR Code

Non-Bacterial Thrombotic Endocarditis in a Patient with Rheumatoid Arthritis

  • Choi, Jung-Hye (Department of Rheumatology, Yonsei University Wonju College of Medicine) ;
  • Park, Jeong-Eun (Department of Rheumatology, Yonsei University Wonju College of Medicine) ;
  • Kim, Jang-Young (Department of Cardiology, Yonsei University Wonju College of Medicine) ;
  • Kang, Taeyoung (Department of Rheumatology, Yonsei University Wonju College of Medicine)
  • Received : 2015.06.06
  • Accepted : 2015.09.22
  • Published : 2016.05.30

Abstract

Rheumatoid arthritis (RA) is frequently associated with various extra-joint complications. Although rare, thromboembolic complications are associated with high morbidity and mortality. We experienced a very rare case of nonbacterial thrombotic endocarditis (NBTE) and subsequent embolic stroke in a patient with RA. A 72-year-old male with a 15-year history of RA suddenly developed neurologic symptoms of vomiting and dizziness. Brain magnetic resonance imaging revealed recently developed multiple cerebellar and cerebral lacunar infarctions. Echocardiography showed a pulsating mitral valve vegetation involving the posterior cusp of the mitral valve leaflet, which was confirmed as NBTE. Immediate anti-coagulation therapy was started. The NBTE lesion disappeared in follow-up echocardiography after 4 weeks of anti-coagulation treatment.

Keywords

References

  1. Eiken PW, Edwards WD, Tazelaar HD, McBane RD, Zehr KJ. Surgical pathology of nonbacterial thrombotic endocarditis in 30 patients, 1985-2000. Mayo Clin Proc 2001;76:1204-12. https://doi.org/10.4065/76.12.1204
  2. Meune C, Touze E, Trinquart L, Allanore Y. Trends in cardiovascular mortality in patients with rheumatoid arthritis over 50 years: a systematic review and meta-analysis of cohort studies. Rheumatology (Oxford) 2009;48:1309-13. https://doi.org/10.1093/rheumatology/kep252
  3. Solomon DH, Karlson EW, Rimm EB, et al. Cardiovascular morbidity and mortality in women diagnosed with rheumatoid arthritis. Circulation 2003;107:1303-7. https://doi.org/10.1161/01.CIR.0000054612.26458.B2
  4. el-Shami K, Griffiths E, Streiff M. Nonbacterial thrombotic endocarditis in cancer patients: pathogenesis, diagnosis, and treatment. Oncologist 2007;12:518-23. https://doi.org/10.1634/theoncologist.12-5-518
  5. Turiel M, Sitia S, Atzeni F, et al. The heart in rheumatoid arthritis. Autoimmun Rev 2010;9:414-8. https://doi.org/10.1016/j.autrev.2009.11.002
  6. Wislowska M, Sypula S, Kowalik I. Echocardiographic findings, 24-hour electrocardiographic Holter monitoring in patients with rheumatoid arthritis according to Steinbrocker's criteria, functional index, value of Waaler-Rose titre and duration of disease. Clin Rheumatol 1998;17:369-77. https://doi.org/10.1007/BF01450894
  7. Aviña-Zubieta JA, Choi HK, Sadatsafavi M, Etminan M, Esdaile JM, Lacaille D. Risk of cardiovascular mortality in patients with rheumatoid arthritis: a meta-analysis of observational studies. Arthritis Rheum 2008;59:1690-7. https://doi.org/10.1002/art.24092
  8. Baghdadi LR, Woodman RJ, Shanahan EM, Mangoni AA. The impact of traditional cardiovascular risk factors on cardiovascular outcomes in patients with rheumatoid arthritis: a systematic review and meta-analysis. PLoS One 2015;10:e0117952. https://doi.org/10.1371/journal.pone.0117952
  9. Kim SC, Solomon DH, Liu J, Franklin JM, Glynn RJ, Schneeweiss S. Risk of venous thromboembolism in patients with rheumatoid arthritis: initiating disease-modifying antirheumatic drugs. Am J Med 2014;128:539.e7-17.
  10. Chatzis A, Giannopoulos N, Baharakakis S, Saridakis N, Agapitos E, Stamatelopoulos S. Unusual cause of a stroke in a patient with seronegative rheumatoid arthritis. Cardiovasc Surg 1999;7:659-60. https://doi.org/10.1016/S0967-2109(99)00013-7
  11. Mounet F, Soula P, Concina P, Baradat G, Cerene A. [Heart valve diseases specific in rheumatoid polyarthritis. Apropos of 2 cases]. Arch Mal Coeur Vaiss 1997;90:987-9.
  12. Kang H, Baron M. Embolic complications of a mitral valve rheumatoid nodule. J Rheumatol 2004;31:1001-3.
  13. Choi HK, Rho YH, Zhu Y, Cea-Soriano L, Avina-Zubieta JA, Zhang Y. The risk of pulmonary embolism and deep vein thrombosis in rheumatoid arthritis: a UK population-based outpatient cohort study. Ann Rheum Dis 2013;72:1182-7. https://doi.org/10.1136/annrheumdis-2012-201669
  14. Bacani AK, Gabriel SE, Crowson CS, Heit JA, Matteson EL. Noncardiac vascular disease in rheumatoid arthritis: increase in venous thromboembolic events? Arthritis Rheum 2012;64:53-61. https://doi.org/10.1002/art.33322
  15. van der Poll T, Büller HR, ten Cate H, et al. Activation of coagulation after administration of tumor necrosis factor to normal subjects. N Engl J Med 1990;322:1622-7. https://doi.org/10.1056/NEJM199006073222302
  16. Ong ML, Veerapen K, Chambers JB, Lim MN, Manivasagar M, Wang F. Cardiac abnormalities in systemic lupus erythematosus: prevalence and relationship to disease activity. Int J Cardiol 1992;34:69-74. https://doi.org/10.1016/0167-5273(92)90084-G
  17. Mazokopakis EE, Syros PK, Starakis IK. Nonbacterial thrombotic endocarditis (marantic endocarditis) in cancer patients. Cardiovasc Hematol Disord Drug Targets 2010;10:84-6. https://doi.org/10.2174/187152910791292484

Cited by

  1. Clinical Manifestations and Mechanisms of Autoimmune Disease-Related Multiple Cerebral Infarcts vol.28, pp.8, 2016, https://doi.org/10.1177/0963689719846838
  2. Rheumatoid arthritis mimicking infective endocarditis with severe aortic regurgitation and aortic root abscess: a case report vol.5, pp.1, 2016, https://doi.org/10.1093/ehjcr/ytaa561
  3. Immunomodulation in antiphospholipid-antibody-associated endocarditis: a case report and review of the literature vol.5, pp.12, 2016, https://doi.org/10.1093/ehjcr/ytab445